OBJECTIVE: To determine the association between inflammatory markers and change in knee pain over 5 years. METHODS: A total of 149 randomly selected subjects (mean 63 years, range 52-78; 46% female) was studied. Serum levels of high sensitivity C-reactive protein (hs-CRP), tumour necrosis factor alpha (TNF-α) and interleukin (IL)-6 were measured at baseline and 2.7 years later. Knee pain was recorded using the Western Ontario and McMasters osteoarthritis index questionnaire at baseline and 5 years later. Knee radiographic osteoarthritis of both knees was assessed at baseline, and knee bone marrow lesions, joint effusion and cartilage defects were determined using T1 or T2-weighted fat saturated MRI. RESULTS: After adjustment for confounding variables, baseline hs-CRP was positively associated with change in total knee pain (β=0.33 per mg/l, p=0.032), as well as change in the pain at night in bed (β=0.12 per ml/pg, p=0.010) and while sitting/lying (β=0.12 per ml/pg, p=0.002). Change in hs-CRP was also associated with change in knee pain at night and when sitting/lying (both p<0.05). Baseline TNFα and IL-6 were associated with change in pain while standing (β=0.06 per ml/pg, p=0.033; β=0.16 per ml/pg, p=0.035, respectively), and change in TNFα was positively associated with change in total knee pain (β=0.66 ml/pg, p=0.020) and change in pain while standing (β=0.26 ml/pg, p=0.002). Adjustment for radiographic osteoarthritis or MRI-detected structural abnormalities led to no or minor attenuation of these associations. CONCLUSION: Systemic inflammation is an independent predictor of worsening knee pain over 5 years.
OBJECTIVE: To determine the association between inflammatory markers and change in knee pain over 5 years. METHODS: A total of 149 randomly selected subjects (mean 63 years, range 52-78; 46% female) was studied. Serum levels of high sensitivity C-reactive protein (hs-CRP), tumour necrosis factor alpha (TNF-α) and interleukin (IL)-6 were measured at baseline and 2.7 years later. Knee pain was recorded using the Western Ontario and McMasters osteoarthritis index questionnaire at baseline and 5 years later. Knee radiographic osteoarthritis of both knees was assessed at baseline, and knee bone marrow lesions, joint effusion and cartilage defects were determined using T1 or T2-weighted fat saturated MRI. RESULTS: After adjustment for confounding variables, baseline hs-CRP was positively associated with change in total knee pain (β=0.33 per mg/l, p=0.032), as well as change in the pain at night in bed (β=0.12 per ml/pg, p=0.010) and while sitting/lying (β=0.12 per ml/pg, p=0.002). Change in hs-CRP was also associated with change in knee pain at night and when sitting/lying (both p<0.05). Baseline TNFα and IL-6 were associated with change in pain while standing (β=0.06 per ml/pg, p=0.033; β=0.16 per ml/pg, p=0.035, respectively), and change in TNFα was positively associated with change in total knee pain (β=0.66 ml/pg, p=0.020) and change in pain while standing (β=0.26 ml/pg, p=0.002). Adjustment for radiographic osteoarthritis or MRI-detected structural abnormalities led to no or minor attenuation of these associations. CONCLUSION: Systemic inflammation is an independent predictor of worsening knee pain over 5 years.
Authors: Hannah Labinsky; Paul M Panipinto; Kaytlyn A Ly; Deric K Khuat; Bhanupriya Madarampalli; Vineet Mahajan; Jonathan Clabeaux; Kevin MacDonald; Peter J Verdin; Jane H Buckner; Erika H Noss Journal: Arthritis Rheumatol Date: 2020-03-12 Impact factor: 10.995
Authors: Kathi L Heffner; Christopher R France; Lisham Ashrafioun; Maria Quiñones; Patrick Walsh; Michael D Maloney; Brian D Giordano; Wilfred R Pigeon Journal: Clin J Pain Date: 2018-12 Impact factor: 3.442
Authors: Vahid Eslami; Mindy J Katz; Robert S White; Erin Sundermann; Julie M Jiang; Ali Ezzati; Richard B Lipton Journal: Gerontology Date: 2016-08-04 Impact factor: 5.140
Authors: Abd El-Moaty Ali Afifi; Reham Magdy Shaat; OLa M Gharbia; Yosra El Boghdadi; Mervat Mohammad El Eshmawy; Ola Ali El-Emam Journal: Clin Rheumatol Date: 2018-07-23 Impact factor: 2.980
Authors: Sharon Bout-Tabaku; Marc P Michalsky; Todd M Jenkins; Amy Baughcum; Meg H Zeller; Mary L Brandt; Anita Courcoulas; Ralph Buncher; Michael Helmrath; Carroll M Harmon; Mike K Chen; Thomas H Inge Journal: JAMA Pediatr Date: 2015-06 Impact factor: 16.193